Michael Ellen O'Callaghan from 8 Crystal Creek Trl, Austin, TX 78737, age 77, Phone: 5122885822

Resumes

Michael O'callaghan

view source

Location:

United States

Michael O'callaghan

view source

Location:

United States

Executive Vice President At Panoramaus

view source

Position:

Executive Vice President at Panoramaus

Location:

Greater Boston Area

Industry:

Biotechnology

Work:

Panoramaus
Executive Vice President

Michael O'callaghan

view source

Location:

United States

Michael O'callaghan

view source

Location:

United States

Name / Title

Company / Classification

Phones & Addresses

Michael O'callaghan
Treasurer

HARVARD LIQUOR SALES, INC

860 Blue Hl Ave, Boston, MA 02122

Michael O'callaghan
President, Treasurer, Director

TIDES AT NAHANT, INC
Eating Place

2B Wilson Rd, Nahant, MA 01908
2 Wilson Rd, Nahant, MA 01908
20 Emerald Rd, Nahant, MA 01908
7812310500, 7815937500

Michael O'callaghan
Executive Vice-President

Panorama Consulting and Engineering Inc.
Biotechnology · Engineering Services · Engineering Services Management Consulting Services

75 Federal St SUITE 901, Boston, MA 02110
12 Hazelwood Ct, Warren, NJ 07059
6175165050

Lawyers & Attorneys

Michael O'Callaghan - Lawyer

view source

ISLN:

910432410

Admitted:

1994

Us Patents

Vegf Antagonist Compositions And Uses Thereof
view source
US Patent:

20130324465, Dec 5, 2013
Filed:

Aug 5, 2011
Appl. No.:

13/814182
Inventors:

James Stefano - Hopkinton MA, US
Clark Pan - Framingham MA, US
Huawei Qiu - Framingham MA, US
Michael O'Callaghan - Framingham MA, US
Gloria Matthews - Framingham MA, US
Assignee:

Genzyem Corporation - Westborough MA
International Classification:

C07K 14/71
C12N 9/12
US Classification:

514 81, 530350, 530410, 4353201, 435 691, 435369
Abstract:

The invention provides compositions and methods for treating a disease or disorder associated with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.

Vegf Antagonist Compositions And Uses Thereof
view source
US Patent:

20160326501, Nov 10, 2016
Filed:

Jul 25, 2016
Appl. No.:

15/218667
Inventors:

- Cambridge MA, US
Clark Pan - Cambridge MA, US
Huawei Qui - Cambridge MA, US
Michael O'Callaghan - Cambridge MA, US
Gloria Matthews - Cambridge MA, US
Assignee:

Genzyme Corporation - Cambridge MA
International Classification:

C12N 9/12
C07K 14/71
Abstract:

The invention provides compositions and methods for treating a disease or disorder associate with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.

Methods For Increasing Muscle Contractility
view source
US Patent:

20150152170, Jun 4, 2015
Filed:

May 23, 2013
Appl. No.:

14/403043
Inventors:

- Concord MA, US
Michael O'Callaghan - Sherborn MA, US
Alan H. Beggs - Needham MA, US
Michael W. Lawlor - Elm Grove WI, US
International Classification:

C07K 16/18
C12N 9/16
Abstract:

The present disclosure provides methods for increasing muscle contractility in a myotubular myopathy subject following administration of fewer than 20 doses of a chimeric polypeptide that has a myotubularin protein and an internalizing moiety.